Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Neurology
|
April 6, 2016
Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease
Dee E Silver, Richard M Trosch
CNS Drugs
|
May 20, 2008
Intermittent subcutaneous apomorphine therapy for 'off' episodes in Parkinson's disease: a 6-month open-label study
Richard M Trosch, Dee Silver, Peter B Bottini
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 26, 2007
Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study
Richard M Trosch, Charles H Adler, Eric J Pappert
Journal of Clinical Movement Disorders
|
July 14, 2018
Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
Vijay P Misra, Richard M Trosch, Pascal Maisonobe, et al.
Expert Review of Neurotherapeutics
|
September 27, 2021
Pain in cervical dystonia: mechanisms, assessment and treatment
Raymond L Rosales, Lorraine Cuffe, Benjamin Regnault, et al.
Journal of the Neurological Sciences
|
May 1, 2007
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose
Rajesh Pahwa, William C Koller, Richard M Trosch, et al.
Clinical Parkinsonism & Related Disorders
|
July 28, 2021
Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
Richard M Trosch, Vijay P Misra, Pascal Maisonobe, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 25, 2015
A Retrospective, Single-Center Comparative Cost Analysis of OnabotulinumtoxinA and AbobotulinumtoxinA for Cervical Dystonia Treatment
Richard M Trosch, Alicia C Shillington, Marci L English, et al.
JAMA Neurology
|
January 14, 2020
Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial
Stuart H Isaacson, William Ondo, Carlayne E Jackson, et al.
Parkinsonism & Related Disorders
|
April 5, 2025
A validation study of the Clinician's Tardive Inventory (CTI)
Richard M Trosch, Alicia C Shillington, Cynthia L Comella, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Neurology
|
April 6, 2016
Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease
Dee E Silver, Richard M Trosch
CNS Drugs
|
May 20, 2008
Intermittent subcutaneous apomorphine therapy for 'off' episodes in Parkinson's disease: a 6-month open-label study
Richard M Trosch, Dee Silver, Peter B Bottini
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 26, 2007
Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study
Richard M Trosch, Charles H Adler, Eric J Pappert
Journal of Clinical Movement Disorders
|
July 14, 2018
Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
Vijay P Misra, Richard M Trosch, Pascal Maisonobe, et al.
Expert Review of Neurotherapeutics
|
September 27, 2021
Pain in cervical dystonia: mechanisms, assessment and treatment
Raymond L Rosales, Lorraine Cuffe, Benjamin Regnault, et al.
Journal of the Neurological Sciences
|
May 1, 2007
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose
Rajesh Pahwa, William C Koller, Richard M Trosch, et al.
Clinical Parkinsonism & Related Disorders
|
July 28, 2021
Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
Richard M Trosch, Vijay P Misra, Pascal Maisonobe, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 25, 2015
A Retrospective, Single-Center Comparative Cost Analysis of OnabotulinumtoxinA and AbobotulinumtoxinA for Cervical Dystonia Treatment
Richard M Trosch, Alicia C Shillington, Marci L English, et al.
JAMA Neurology
|
January 14, 2020
Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial
Stuart H Isaacson, William Ondo, Carlayne E Jackson, et al.
Parkinsonism & Related Disorders
|
April 5, 2025
A validation study of the Clinician's Tardive Inventory (CTI)
Richard M Trosch, Alicia C Shillington, Cynthia L Comella, et al.
Page
of 2